Agena Bioscience (Agena), a San-Diego-based develops, manufactures, and supplies genetic analysis systems and reage...
Reistone Biopharma Company Limited, a clinical stage biopharmaceutical company headquartered in Shanghai has announced&...
Cancer Genetics, Inc., a leader in enabling precision medicine for immuno-oncology and genomics through molecular marker...
Hutchison China MediTech Limited (Chi-Med) has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase (...
Changchun Changsheng Life Sciences Ltd has been charged with a huge fine of $1.3 billion for falsifying production recor...
JHL Biotech announced that the National Medical Products Administration of the PRC (NMPA) has approved JHL's Phase I and...
Curetis, a developer of next-level molecular diagnostic solutions, has announced that it has significantly expanded its ...
MEI Pharma, a late-stage pharmaceutical company focused on advancing new therapies for cancer and BeiGene, a commer...
Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer th...
Shanghai UniCAR-Therapy Bio-Medicine Technology Co. chose Terumo BCT and its cell expansion devices to automate its cell...
With a potential market size of more than RMB100 billion, assisted reproduction has become one of the fastest growing ma...
The Hong Kong Polytechnic University (PolyU) has developed eNightLog, a multi-function nighttime monitoring system for e...
Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and mar...
Deep Intelligent Pharma, a healthcare AI start-up providing new drug research and development services for pharmaceutica...
CASI Pharmaceuticals, a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effect...
Cellular Biomedicine Group Inc. (CBMG), a clinical-stage biopharmaceutical firm engaged in the development of immunother...
AXA Hong Kong and HKSH Medical Group has entered into collaboration under which HKSH will be the first and biggest partn...
Singapore - Gilead Sciences announced that the Hong Kong Department of Health has approved Biktarvy (bictegravir 50mg/em...
China's leading one-stop healthcare ecosystem platform, Ping An Good Doctor (PAGD) has announced that it has entered int...
CANbridge Pharmaceutical Inc., a biopharmaceutical company developing Western drug candidates in China and North Asia, a...
Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cance...
Cellular Biomedicine Group Inc. (CBMG) has entered into a strategic licensing and collaboration agreement with Novartis ...
Ahon Pharmaceutical Co Ltd., a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co. Ltd, and DiaMedica Therapeutics I...
Ascletis Pharma Inc. announced that Ganovo (Danoprevir) has been enrolled in the Basic Medical Insurance of Tianjin...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
Agilent Technologies Inc. has announced that it has signed a definitive agreement to acquire privately-owned ACEA Biosci...
Singapore - Fullerton Healthcare Corporation Limited, a leading vertically integrated healthcare platform in the As...
China's biopharma firm Changchun High & New Technology Industries have teamed up with Iceland's drugmaker Alvotech t...
Researchers from Jinan University in China have developed a smart photoacoustic imaging approach by using a combination ...
Innovent Biologics, a world-class China-based biopharmaceutical company that develops and commercializes high quality dr...
CPhI Worldwide the world’s largest pharma event taking place in Madrid (9-11, October 2018) and org...
Huami Corporation, a biometric and activity data-driven company with significant expertise in smart wearable technology,...
Agendia, Inc., a world leader in precision oncology has announced that it has entered into an exclusive commercial partn...
Global growth equity firm General Atlantic has invested $150 million in Chinese healthcare services provider and hospita...
BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly...
Genecast Biotechnology Co. Ltd. has announced it has just reached strategic partnership agreement with the global leader...
A new agreement has been signed between the Fijian and Chinese governments that will see the construction of a health an...
Shuwen Biotech is the first in China to launch a locally manufactured proprietary PD-L1 test kit, which can accurately d...
Chow Tai Fook is collaborating with BookDoc, the largest integrated healthcare app in Southeast Asia ...
EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, has ...
This year at the Eastern Economic Forum in Vladivostok, BIOCAD and Shanghai Pharmaceuticals Holding entered into a Memor...
A recent circular issued by the Chinese State Drug Administration (SDA), has opened up a large market for Contract Resea...
WuXi Biologics (2269.HK, WuXi Bio), a leading global open-access biologics technology platform company offering end-to-e...
XW Laboratories Inc. (XW Labs), a clinical-stage biopharmaceutical company focused on developing innovative small molecu...
China has developed its own heart stent and has published its clinical trial results online in the world-leading medical...
Biocartis Group NV, an innovative molecular diagnostics company, and Guangzhou Wondfo Biotech Co., Ltd., a fast growing ...
WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of fruquintinib capsules (Elunate...
Chinese online B2C pharmacy and healthcare services platform Jianke has announced that it has successfully closed a...
Singapore - Eisai and collaboration partner Merck announce that the China National Medical Products Administration ...
China-based Chi-Med has announced that fruquintinib capsules have been granted approval for drug registration by the Nat...
Chinese researchers say they have developed an artificial intelligence (AI) model with medical imaging to accurately det...
Boehringer Ingelheim (BI) and Tsinghua University in Beijing have announced a collaboration aiming to research and devel...
Asia Pacific is predicted to be the fastest growing market for synthetic biology from 2018 to 2025, driving increased de...
Bio-Thera Solutions, a global biopharmaceutical company recently announced that the China National Drug Administration (...
XingImaging LLC, a radiopharmaceutical production and positron emission tomography (PET) acquisition company operating i...
WeDoctor, Mason Group and Aldworth Management have agreed to pay up to $510 million to acquire an 89.5 per cent stake in...
Suven Life Sciences has said that it has been granted a product patent each by China and Eurasia corresponding to a new ...
Qiming Capital and Hillhouse Capital recently led a $55 million series C round in Jacobio Pharmaceuticals, a Beijing-bas...
Ascletis Pharma Inc. has announced that Mr. Joshua Zhongbao Ling joined Ascletis as Vice President of Finance. Mr. Ling ...
China's leading one-stop healthcare ecosystem platform, Ping An Good Doctor recently announced its strategic partnership...
DNAnexus, the global leader in genome informatics and data management, today announced details of an opportun...
China's commercial-stage biopharmaceutical company BeiGene, recently announced the acceptance by the Ch...
Singapore – ECON Healthcare Group signed a Memorandum of Understanding (MOU) with Chongqing Civil Affairs Bureau u...
Strategia Holdings, LLC has announced a strategic partnership alliance with JS InnoPharm (Shanghai), Ltd. to facilitate ...
Mabpharm, a CDH Investments-backed Chinese biopharmaceutical firm has filed for an initial public offering in Hong ...
China Biologic Products Holdings, a leading fully integrated plasma-based biopharmaceutical company in China, announced ...
GL Capital, a healthcare-focused value-driven investment management group in China, has invested $12.5 million in UK-lis...
The Xu lab at Shanghai University's iHuman Institute has deciphered the high-resolution crystal structure of the fi...
At the end of 2017, Chongqing Food and Drug Administration of China Food and Drug Administration (CFDA) officially appro...
IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics tech...
Harbour BioMed has announced it has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharma...
A consortium composed of Mr. David (Xiaoying) Gao, GL Capital Group, Bank of China Group Investment Limited and CDH Inve...
The China Food and Drug Administration's Institute of Executive Development (CFDAIED) has signed an exclusive memorandum...
Roche recently announced that the China National Drug Administration (CNDA) has granted marketing authorization fo...
Adlai Nortye, a Hangzhou biopharma, has announced the opening of its first US site in Boston, Massachusetts. The Boston ...
HitGen Ltd has announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small m...
A team of researchers led by Dr. Paddy Chan Kwok-leung of the Mechanical Engineering Department at the University of Hon...
China's leading one-stop healthcare ecosystem platform, Ping An Healthcare and Technology Company Limited has announced ...
Shanghai ChemPartner, a leading life science organization providing high-quality and cost-effective drug discovery and d...
Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines ...
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance ...
Haisco Pharmaceutical Group Co Ltd, a China-based company focused on the research and development and marketing of thera...
Synergy Pharmaceuticals recently announced that the company has entered into a license agreement with Luoxin Pharm...
JHL Biotech has received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of ...
EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into ...
Australian and Chinese scientists have developed a method using coded nanoparticles to detect and help diagnose disease....
Ascletis Pharma Inc announced Ravidasvir is recommended by the World Health Organization (WHO) Guidelin...
On August 8, 2018, Beijing time I-Mab Biopharma ("I-Mab"), a Shanghai-based biotech company focused on innovative biolog...
Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbocic...
Glenmark Pharmaceuticals S.A. and Harbour BioMed have entered into an exclusive license agreement for the Greater C...
Cure Genetics Co., Ltd., a biotechnology company dedicated to the development of life-saving transformative medicines an...
IMPACT Therapeutics a China-based clinical-stage biopharmaceutical company dedicated to the discovery and development of...
Laekna Inc., a biotechnology company headquartered in Shanghai has announced the signing of an agreement with Novartis P...
Legend Capital, the venture and growth capital arm of China’s Legend Holdings Ltd, has co-led an RMB2 billion ($29...
Chinese medical solution provider Medlinker has raised a RMB1 billion ($146.8 million) series D round led by China Capit...
Ascletis has received the acceptance letter from the China Food and Drug Administration (CFDA) for Ravidasvir (RDV) new ...
Orig3n, Inc., a Boston-based biotech company pioneering the future of health through genetics and regenerative medicine,...
Ascletis announced that the Ganovo phase III clinical study won the top clinical research award at the 15th National Con...
Shanghai-based biopharma firm Curon Biopharmaceutical has announced the completion of its Series A funding round, which ...
China Stem Cell Group Co Ltd, a Shanghai-based company has announced the opening of its affiliated stem cell hospital in...
